CSF-VDRL testVenereal disease research laboratory slide test - CSF; Neurosyphilis - VDRL
How the Test is Performed
How to Prepare for the Test
Follow the health care provider's instructions on how to prepare for this test.
Why the Test is Performed
The CSF-VDRL test is done to diagnose syphilis in the brain or spinal cord. Brain and spinal cord involvement is often a sign of late-stage syphilis.
A negative result is normal.
False-negatives can occur. This means you can have syphilis even if this test is normal. Therefore, a negative test does not always rule out the infection. Other signs and tests may be used to diagnose neurosyphilis.
What Abnormal Results Mean
A positive result is abnormal and is a sign of neurosyphilis.
Risks of this test are those related to lumbar puncture, which may include:
- Bleeding into the spinal canal or around the brain (subdural hematomas).
- Discomfort during the test.
- Headache after the test that can last a few hours or days. If headaches last more than a few days (especially when you sit, stand or walk) you might have a CSF-leak. You should talk to your physician if this occurs.
- Hypersensitivity (allergic) reaction to the anesthetic.
- Infection introduced by the needle going through the skin.
Your provider can tell you about any other risks.
Chernecky CC, Berger BJ. Venereal disease research laboratory test (VDRL), test, cerebrospinal fluid – specimen. In: Chernecky CC, Berger BJ, eds. Laboratory Tests and Diagnostic Procedures. 6th ed. St Louis, MO: Elsevier Saunders; 2013:1166.
Radolf JD, Tramont EC, Salazar JC. Syphilis (Treponema pallidum). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Updated Edition. 8th ed. Philadelphia, PA: Elsevier Saunders; 2015:chap 239.
Review Date: 9/27/2017
Reviewed By: Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.